Ovation Bio Technologies Pvt Ltd - Company Profile
Content
Ovation Biotechnologies Pvt. Ltd.
February 2012
Contents
Ovation Biotechnologies Pvt. Ltd.
Executive Summary Factsheet Offices & Centres Key Products and Services Key People SWOT Analysis Financial Profile Industry Analysis Competitive Landscape Competitive Benchmarking Appendix
2
Executive Summary
Company Description Key Products and Services SWOT Analysis
• Ovation Biotechnologies Pvt. Ltd. is headquartered in A and engages in B, C and D • The company is T certified and its products are P • It manufactures medical equipments under various segments such as T, M, O and V
• Strength 1 is one of the major strengths of the company; however weakness 1 is one of the key areas of concern • The company can reap significant benefits owing to opportunity 1 while threat 1 may have an adverse affect on the strategic initiatives and growth prospects of the organization • Ovation Biotechnologies Pvt. Ltd. generated total revenues of INR A mn in the fiscal year (FY) 20‐‐ registering a y‐o‐y decrease of x per cent. It earned a net profit of INR N mn in FY 20‐‐ as compared to a net profit of P mn in FY 20‐‐ • The financial profile of the company includes the balance sheet, profit and loss a/c and the key ratios depicting the key financial figures for FY 20‐‐, 20‐‐, 20‐‐ and 20‐‐, giving an insight into the company's financial performance • Medical Equipments market is estimated at INR A bn in FY 20‐‐ and expected to grow at a CAGR of x per cent to reach INR B bn in FY 20‐‐ • The Medical Equipments market is classified into segments such as P, Q, R and S • The Surgical Instruments market in India is estimated at INR A bn in FY 20‐‐ and is expected to grow at a CAGR of x per cent to reach INR B bn by FY 20‐‐ • The key drivers are A, B, C and D
Financial Profile
Industry Analysis
Competitive Landscape
• Key competitors for the company can be enlisted as: Competitor 1 and Competitor 2
3
Factsheet
Basic Information
Industry Corporate Address ‐‐ ‐‐
Brief Description
• Ovation Biotechnologies Pvt. Ltd. (Ovation) is headquartered in A and engages in B, C and D • The company is T certified and its products are M • It manufactures products under segments such as: •T
Tel No. Fax No. Website Year Founded Year of Incorporation Ownership Revenue Fiscal Year End Auditor Key Competitors
‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐
•I •S •G
• It manufactures products such as S, P, Y, L, A, F, C, Z, J, O, etc.
P M A S
LE
Brief History
• 20‐‐:
Source:
4
Offices & Centres – India
P M SA
LE
Headquarters
Note: Source:
5
Key Products and Services
The company generates revenue through its products which include:
Ovation Biotechnologies Pvt. Ltd.
Product 1
Product 2
Product 3
Product 4
• ‐‐
•‐‐
• ‐‐
• ‐‐
L E MP SA
Source:
6
Key People
Key People
Name Designation Age (years) Date of Appointment
Ownership Structure
Total Paid‐up Capital Total Number of shareholders
INR A ‐
‐‐ ‐‐ ‐‐ ‐‐
‐‐ ‐‐ ‐‐ ‐‐
‐‐ ‐‐ ‐‐ ‐‐
‐‐ ‐‐ ‐‐ ‐‐
Shareholders of the Company
Name ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐
Source:
Shareholding Pattern
‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐
Note:
No. of Shares Held
P M SA
P x%
LE
7
SWOT Analysis (1/2)
Strengths
• Strength 1
Weakness
• Weakness 1
• Strength 2
Internal Factors
E L P M SA
Source:
8
SWOT Analysis (2/2)
Opportunities
• Opportunity 1 • Threat 1
Threats
• Opportunity 2
• Threat 2
External Factors
E L P M SA
Source:
9
Financial Profile
Financial Snapshot
Total Income Net Profit/Loss after tax INR mn
10
Profit & Loss Statement
Particulars
Operating Income
2008
‐
2009
‐
2010
‐
2011
‐
E
8 6 4 2 0
C G A B 20‐‐ D 20‐‐ 20‐‐ F H 20‐‐
Total Income
‐
‐
‐
‐
Expenditure (below) Total Expenditure
‐
‐
‐
‐
‐
‐
‐
‐
Financial Summary
• Analysis Point 1 • Analysis Point 2
• Analysis Point 3
LE P M SA
Profit/(Loss) after Tax
‐
‐
‐
‐
Source:
Note:
10
Ratio Analysis
Key Ratios
Particulars y‐o‐y change (2011‐10)
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
Key Ratio Analysis
2011 2010 2009 2008
• Analysis Point 1 • Analysis Point 2
Profitability Ratios
Net Margin Return on Equity Return on Working Capital Return on Assets Return on Fixed Assets
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
• Analysis Point 3 • Analysis Point 4 • Analysis Point 5
Liquidity Ratios
Current Ratio Cash Ratio
P L E SAM
Efficiency Ratios
Fixed Asset Turnover Asset Turnover Current Asset Turnover Working Capital Turnover Capital Employed Turnover
Source:
Improved
Decline
Note:
11
Annual Financial Ratios
Profitability Ratios
1.6 1.4 1.2 1.0 0.8 0.6 0.4 0.2 0.0 2008 2009 2010
20 15 10 5
30 25 20 15 10 5 0 2008
Source:
LE MP SA
0 2011 2008 2009
80 60 40 20 0 2011 2008 2009
2010
2011
2009
2010
2010
2011
12
Industry Analysis
Medical Equipment Industry – Overview
• The Medical Equipment market is estimated at INR A bn in FY 20‐‐ and expected to grow at a CAGR of x per cent to reach INR B bn by FY 20‐‐ • This market can be classified into segments such as C, D, E and F • Indian medical equipment market imports y per cent of its medical equipments from countries such as M, N, O, P • Major trends observed in the medical equipment market are:
Trend 1 Trend 2 Trend 3 Trend 4 Trend 5
Market Size & Growth (20‐‐ ‐20‐‐e)
INR bn
100 80 60 40 20 0
20‐‐ 20‐‐ 20‐‐e A B C
G x% D E F
• Some of the key drivers of the medical equipment market are:
Driver 1 Driver 2 Driver 3 Driver 4 Driver 5
P M SA
LE
20‐‐e
20‐‐e
20‐‐e
20‐‐e
Market Segmentation (FY 20‐‐)
a% d% M N O c% b% P
• Some of the Government initiatives towards the Medical equipment market were:
Point 1 Point 2
Source:
13
Industry Analysis
Surgical Instruments Market – Overview
• The Surgical Instruments market in India is estimated at INR A bn in FY 20‐‐ and is expected to grow at a CAGR of x per cent to reach INR B bn by FY 20— • Surgical Instruments is a part of the X • Some of the key drivers of the surgical instruments market are:
‐‐ ‐‐ ‐‐ ‐‐
Market Size & Growth (20‐‐ ‐20‐‐e)
INR bn
25 20 15 10 5 0
x% P Q R S
T
U
E PL AM S
20‐‐
20‐‐
20‐‐e
20‐‐e
20‐‐e
20‐‐e
Import ‐ Export Pattern of Major Surgical Instruments
INR mn
3,000 2,000
Imports D B A C E F G
Exports H
• Some of the major trends are:
A B C
1,000 0
20-12%
HS Code ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐
20--
20-49% HS Code Description
‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐
20--
Source:
14
Competitive Landscape (1/2)
Company Name Company 1
• ‐‐ • ‐‐ • ‐‐
Description
Company 2
‐‐ ‐‐ ‐‐
LE MP SA
15
Source:
Competitive Landscape (2/2)
Competitive Scenario
Company Name
Company A
Company B
Financial Information (INR mn – FY 2010)
Company C
Total Revenue Net Profit/(loss)
‐‐ ‐‐
‐‐ ‐‐
Major Market Segmentation (Medical Equipments)
‐‐ ‐‐
Surgical Instruments Sutures \ Suture Needles Cannulas Forceps Scissors Retractors Catheters Blades Knives Scalpel
Source:
H: High; L: Low; M: Medium
SAMPLE
Offered
Not Offered
16
Competitive Benchmarking (1/2)
Key Financial Ratios – FY 2011 (1/2)
%
1.2 1.0 0.8 0.6 0.4 0.2 0.0
M
B
A
• Analysis Point 1 • Analysis Point 2
X
Y
N
%
6 5 4 3 2 1 0
D
E PL AM S
• Analysis Point 3 • Analysis Point 4 17
C
X
Source:
Y
Thank you for the attention
Ovation Biotechnologies Pvt. Ltd. is a part of Netscribes’ Healthcare Company Profile Series.
For more detailed information or customized research requirements please contact:
Jitendra Punjabi
Phone: E‐Mail: +91 33 4064 6215 [email protected]
About Netscribes Netscribes is a knowledge‐consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, content‐management services, and knowledge‐software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes is a one‐stop shop designed to fulfil clients’ profitability and growth objectives. This report is published for general information only. Although high standards have been used in preparing this report, Netscribes (India) Pvt. Ltd. or Netscribes is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes (India) Pvt. Ltd. and no part may be reproduced without prior written permission.
www.netscribes.com
18
February 2012
Contents
Ovation Biotechnologies Pvt. Ltd.
Executive Summary Factsheet Offices & Centres Key Products and Services Key People SWOT Analysis Financial Profile Industry Analysis Competitive Landscape Competitive Benchmarking Appendix
2
Executive Summary
Company Description Key Products and Services SWOT Analysis
• Ovation Biotechnologies Pvt. Ltd. is headquartered in A and engages in B, C and D • The company is T certified and its products are P • It manufactures medical equipments under various segments such as T, M, O and V
• Strength 1 is one of the major strengths of the company; however weakness 1 is one of the key areas of concern • The company can reap significant benefits owing to opportunity 1 while threat 1 may have an adverse affect on the strategic initiatives and growth prospects of the organization • Ovation Biotechnologies Pvt. Ltd. generated total revenues of INR A mn in the fiscal year (FY) 20‐‐ registering a y‐o‐y decrease of x per cent. It earned a net profit of INR N mn in FY 20‐‐ as compared to a net profit of P mn in FY 20‐‐ • The financial profile of the company includes the balance sheet, profit and loss a/c and the key ratios depicting the key financial figures for FY 20‐‐, 20‐‐, 20‐‐ and 20‐‐, giving an insight into the company's financial performance • Medical Equipments market is estimated at INR A bn in FY 20‐‐ and expected to grow at a CAGR of x per cent to reach INR B bn in FY 20‐‐ • The Medical Equipments market is classified into segments such as P, Q, R and S • The Surgical Instruments market in India is estimated at INR A bn in FY 20‐‐ and is expected to grow at a CAGR of x per cent to reach INR B bn by FY 20‐‐ • The key drivers are A, B, C and D
Financial Profile
Industry Analysis
Competitive Landscape
• Key competitors for the company can be enlisted as: Competitor 1 and Competitor 2
3
Factsheet
Basic Information
Industry Corporate Address ‐‐ ‐‐
Brief Description
• Ovation Biotechnologies Pvt. Ltd. (Ovation) is headquartered in A and engages in B, C and D • The company is T certified and its products are M • It manufactures products under segments such as: •T
Tel No. Fax No. Website Year Founded Year of Incorporation Ownership Revenue Fiscal Year End Auditor Key Competitors
‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐
•I •S •G
• It manufactures products such as S, P, Y, L, A, F, C, Z, J, O, etc.
P M A S
LE
Brief History
• 20‐‐:
Source:
4
Offices & Centres – India
P M SA
LE
Headquarters
Note: Source:
5
Key Products and Services
The company generates revenue through its products which include:
Ovation Biotechnologies Pvt. Ltd.
Product 1
Product 2
Product 3
Product 4
• ‐‐
•‐‐
• ‐‐
• ‐‐
L E MP SA
Source:
6
Key People
Key People
Name Designation Age (years) Date of Appointment
Ownership Structure
Total Paid‐up Capital Total Number of shareholders
INR A ‐
‐‐ ‐‐ ‐‐ ‐‐
‐‐ ‐‐ ‐‐ ‐‐
‐‐ ‐‐ ‐‐ ‐‐
‐‐ ‐‐ ‐‐ ‐‐
Shareholders of the Company
Name ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐
Source:
Shareholding Pattern
‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐
Note:
No. of Shares Held
P M SA
P x%
LE
7
SWOT Analysis (1/2)
Strengths
• Strength 1
Weakness
• Weakness 1
• Strength 2
Internal Factors
E L P M SA
Source:
8
SWOT Analysis (2/2)
Opportunities
• Opportunity 1 • Threat 1
Threats
• Opportunity 2
• Threat 2
External Factors
E L P M SA
Source:
9
Financial Profile
Financial Snapshot
Total Income Net Profit/Loss after tax INR mn
10
Profit & Loss Statement
Particulars
Operating Income
2008
‐
2009
‐
2010
‐
2011
‐
E
8 6 4 2 0
C G A B 20‐‐ D 20‐‐ 20‐‐ F H 20‐‐
Total Income
‐
‐
‐
‐
Expenditure (below) Total Expenditure
‐
‐
‐
‐
‐
‐
‐
‐
Financial Summary
• Analysis Point 1 • Analysis Point 2
• Analysis Point 3
LE P M SA
Profit/(Loss) after Tax
‐
‐
‐
‐
Source:
Note:
10
Ratio Analysis
Key Ratios
Particulars y‐o‐y change (2011‐10)
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
Key Ratio Analysis
2011 2010 2009 2008
• Analysis Point 1 • Analysis Point 2
Profitability Ratios
Net Margin Return on Equity Return on Working Capital Return on Assets Return on Fixed Assets
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
• Analysis Point 3 • Analysis Point 4 • Analysis Point 5
Liquidity Ratios
Current Ratio Cash Ratio
P L E SAM
Efficiency Ratios
Fixed Asset Turnover Asset Turnover Current Asset Turnover Working Capital Turnover Capital Employed Turnover
Source:
Improved
Decline
Note:
11
Annual Financial Ratios
Profitability Ratios
1.6 1.4 1.2 1.0 0.8 0.6 0.4 0.2 0.0 2008 2009 2010
20 15 10 5
30 25 20 15 10 5 0 2008
Source:
LE MP SA
0 2011 2008 2009
80 60 40 20 0 2011 2008 2009
2010
2011
2009
2010
2010
2011
12
Industry Analysis
Medical Equipment Industry – Overview
• The Medical Equipment market is estimated at INR A bn in FY 20‐‐ and expected to grow at a CAGR of x per cent to reach INR B bn by FY 20‐‐ • This market can be classified into segments such as C, D, E and F • Indian medical equipment market imports y per cent of its medical equipments from countries such as M, N, O, P • Major trends observed in the medical equipment market are:
Trend 1 Trend 2 Trend 3 Trend 4 Trend 5
Market Size & Growth (20‐‐ ‐20‐‐e)
INR bn
100 80 60 40 20 0
20‐‐ 20‐‐ 20‐‐e A B C
G x% D E F
• Some of the key drivers of the medical equipment market are:
Driver 1 Driver 2 Driver 3 Driver 4 Driver 5
P M SA
LE
20‐‐e
20‐‐e
20‐‐e
20‐‐e
Market Segmentation (FY 20‐‐)
a% d% M N O c% b% P
• Some of the Government initiatives towards the Medical equipment market were:
Point 1 Point 2
Source:
13
Industry Analysis
Surgical Instruments Market – Overview
• The Surgical Instruments market in India is estimated at INR A bn in FY 20‐‐ and is expected to grow at a CAGR of x per cent to reach INR B bn by FY 20— • Surgical Instruments is a part of the X • Some of the key drivers of the surgical instruments market are:
‐‐ ‐‐ ‐‐ ‐‐
Market Size & Growth (20‐‐ ‐20‐‐e)
INR bn
25 20 15 10 5 0
x% P Q R S
T
U
E PL AM S
20‐‐
20‐‐
20‐‐e
20‐‐e
20‐‐e
20‐‐e
Import ‐ Export Pattern of Major Surgical Instruments
INR mn
3,000 2,000
Imports D B A C E F G
Exports H
• Some of the major trends are:
A B C
1,000 0
20-12%
HS Code ‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐
20--
20-49% HS Code Description
‐‐ ‐‐ ‐‐ ‐‐ ‐‐ ‐‐
20--
Source:
14
Competitive Landscape (1/2)
Company Name Company 1
• ‐‐ • ‐‐ • ‐‐
Description
Company 2
‐‐ ‐‐ ‐‐
LE MP SA
15
Source:
Competitive Landscape (2/2)
Competitive Scenario
Company Name
Company A
Company B
Financial Information (INR mn – FY 2010)
Company C
Total Revenue Net Profit/(loss)
‐‐ ‐‐
‐‐ ‐‐
Major Market Segmentation (Medical Equipments)
‐‐ ‐‐
Surgical Instruments Sutures \ Suture Needles Cannulas Forceps Scissors Retractors Catheters Blades Knives Scalpel
Source:
H: High; L: Low; M: Medium
SAMPLE
Offered
Not Offered
16
Competitive Benchmarking (1/2)
Key Financial Ratios – FY 2011 (1/2)
%
1.2 1.0 0.8 0.6 0.4 0.2 0.0
M
B
A
• Analysis Point 1 • Analysis Point 2
X
Y
N
%
6 5 4 3 2 1 0
D
E PL AM S
• Analysis Point 3 • Analysis Point 4 17
C
X
Source:
Y
Thank you for the attention
Ovation Biotechnologies Pvt. Ltd. is a part of Netscribes’ Healthcare Company Profile Series.
For more detailed information or customized research requirements please contact:
Jitendra Punjabi
Phone: E‐Mail: +91 33 4064 6215 [email protected]
About Netscribes Netscribes is a knowledge‐consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, content‐management services, and knowledge‐software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes is a one‐stop shop designed to fulfil clients’ profitability and growth objectives. This report is published for general information only. Although high standards have been used in preparing this report, Netscribes (India) Pvt. Ltd. or Netscribes is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes (India) Pvt. Ltd. and no part may be reproduced without prior written permission.
www.netscribes.com
18
